Portfolio Update

RNS Number : 9640Z

Intl. Biotechnology Trust PLC

20 December 2017

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 30 November 2017

Net Assets	£227m
Net Assets per share	603p
Share price	609p
Total value of unquoted investments	£19m
Total number of portfolio companies	93
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Biogen	7.5
Celgene	5.4
Adamas	5.3
Regeneron	4.8
Nektar	4.0
Vertex	4.0
Exelixis	3.9
Acadia	3.3
Gilead	3.0
Genmab	2.9
	-----------
Total	44.1

Geographical Allocation	% NAV
US & Canada	90
Europe & UK	10
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	92
Unquoted	8
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	28
Mid Cap =USD1-10BN	36
Small Cap <USD1BN	36
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	40
CNS	13
Rare diseases	11
Inflammation	8
Ophthalmology	7
Infectious Diseases	6
Metabolic	4
Medtech	2
Other	9
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

20 DECEMBER 2017

 

END

 

 

PFUBXBDDCSDBGRG